AMN Healthcare Services, Inc. (AMN) 10-Year Financial Performance & Capital Metrics

AMN •

HealthcareHealthcare FacilitiesHealthcare staffing and facility services

AboutAMN Healthcare Services, Inc. provides healthcare workforce solutions and staffing services to hospitals and healthcare facilities in the United States. It operates through three segments: Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions. The Nurse and Allied Solutions segment offers travel nurse staffing, rapid response nurse staffing and labor disruption, allied staffing, local staffing, and revenue cycle solutions. The Physician and Leadership Solutions segment provides locum tenens staffing, healthcare interim leadership staffing, executive search, and physician permanent placement solutions. The Technology and Workforce Solutions segment offers language services, vendor management systems, workforce optimization, telehealth, credentialing, and outsourced solutions. The company also provides allied health professionals, such as physical therapists, respiratory therapists, occupational therapists, medical and radiology technologists, lab technicians, speech pathologists, rehabilitation assistants, and pharmacists. It offers its services under the brands, including American Mobile, Nursefinders, NurseChoice, HealthSource Global Staffing, Onward Healthcare, O'Grady Peyton International, Med Travelers, Club Staffing, Staff Care, B.E. Smith, and Merritt Hawkins, as well as AMN Revenue Cycle Solutions and AMN Language Services. The company was founded in 1985 and is based in Dallas, Texas.Show more

Revenue $2.98B -21.3%
EBITDA $71M -85.8%
Net Income -$147M -169.8%
EPS (Diluted) -3.85 -171.8%
Gross Margin 30.81% -6.6%
EBITDA Margin 2.38% -81.9%
Operating Margin -3.44% -138.5%
Net Margin -4.93% -188.6%
ROE -19.11% -185.1%
ROIC -3.91% -130.7%
Debt/Equity 1.55 -4.4%
Interest Coverage -1.47 -123.5%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Share count reduced 2.9% through buybacks
✓Trading at only 1.1x book value
✓Efficient asset utilization: 1.2x turnover

✗Weaknesses

No significant weaknesses identified

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y11.16%

5Y6.07%

3Y-9.19%

TTM-8.49%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM34.89%

EPS CAGR

10Y-

5Y-

3Y-

TTM35.36%

ROCE

10Y Avg17.51%

5Y Avg14.71%

3Y Avg13.88%

Latest-4.96%

Peer Comparison

Healthcare staffing and facility services

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
CCELCryo-Cell International, Inc.	27.15M	3.37	67.40	2.05%	1.26%		13.29%
HCSGHealthcare Services Group, Inc.	1.67B	21.77	26.88	7.08%	2.2%	8.01%	8.32%	0.03
SOLVSolventum Corporation	12.87B	74.20	8.36	0.86%	18.69%	30.82%		1.00
AMSAmerican Shared Hospital Services	13.74M	2.11	6.39	32.9%	-7.65%	-7.87%		0.77
SYRASyra Health Corp. Class A Common Stock	60K	0.10	-0.19	44.73%	-16.89%	-57.31%		0.16
AMNAMN Healthcare Services, Inc.	987.48M	19.48	-5.06	-21.26%	-3.5%	-14.9%	24.26%	1.55
CCRNCross Country Healthcare, Inc.	280.81M	8.70	-19.77	-33.46%	-1.39%	-3.84%	39.67%	0.01

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	1.46B	1.9B	1.99B	2.14B	2.22B	2.39B	3.98B	5.24B	3.79B	2.98B
Revenue Growth %	41.22%	30.02%	4.53%	7.42%	4.03%	7.72%	66.45%	31.6%	-27.73%	-21.26%
Cost of Goods Sold+	993.7M	1.28B	1.34B	1.44B	1.48B	1.6B	2.67B	3.53B	2.54B	2.06B
COGS % of Revenue	67.92%	67.42%	67.59%	67.4%	66.54%	66.92%	67.13%	67.26%	67.02%	69.19%
Gross Profit+	469.36M	619.72M	644.42M	696.38M	743.47M	791.78M	1.31B	1.72B	1.25B	919.38M
Gross Margin %	32.08%	32.58%	32.41%	32.6%	33.46%	33.08%	32.87%	32.74%	32.98%	30.81%
Gross Profit Growth %	48.48%	32.04%	3.98%	8.06%	6.76%	6.5%	65.4%	31.08%	-27.21%	-26.43%
Operating Expenses+	340.48M	428.09M	431.98M	493.56M	566.55M	642.51M	831.6M	1.07B	911.15M	1.02B
OpEx % of Revenue	23.27%	22.5%	21.72%	23.11%	25.5%	26.84%	20.87%	20.4%	24.05%	34.25%
Selling, General & Admin	319.53M	398.47M	399.7M	452.32M	508.03M	549.75M	730.45M	936.58M	756.24M	632.49M
SG&A % of Revenue	21.84%	20.95%	20.1%	21.18%	22.86%	22.97%	18.33%	17.86%	19.96%	21.2%
Research & Development	0	0	0	0	0	0	0	0	0	0
R&D % of Revenue	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	20.95M	29.62M	32.28M	41.24M	58.52M	92.77M	101.15M	133.01M	154.91M	389.56M
Operating Income+	128.88M	191.63M	212.44M	202.83M	176.91M	149.26M	478M	647.1M	338.43M	-102.67M
Operating Margin %	8.81%	10.07%	10.68%	9.5%	7.96%	6.24%	12%	12.34%	8.93%	-3.44%
Operating Income Growth %	89.8%	48.69%	10.86%	-4.52%	-12.78%	-15.63%	220.23%	35.38%	-47.7%	-130.34%
EBITDA+	149.83M	221.25M	244.72M	244.06M	235.44M	243.45M	581.7M	784.21M	499.36M	71.11M
EBITDA Margin %	10.24%	11.63%	12.31%	11.43%	10.6%	10.17%	14.6%	14.96%	13.18%	2.38%
EBITDA Growth %	78.59%	47.67%	10.61%	-0.27%	-3.54%	3.41%	138.94%	34.82%	-36.32%	-85.76%
D&A (Non-Cash Add-back)	20.95M	29.62M	32.28M	41.24M	58.52M	94.19M	103.7M	137.11M	160.93M	173.78M
EBIT	128.88M	191.63M	212.44M	202.83M	176.91M	149.26M	478M	647.1M	338.43M	-102.67M
Net Interest Income+	-7.79M	-15.46M	-19.68M	-16.14M	-28.43M	-57.74M	-34.08M	-40.4M	-54.14M	-69.9M
Interest Income	0	0	0	0	0	0	0	0	0	0
Interest Expense	7.79M	15.46M	19.68M	16.14M	28.43M	57.74M	34.08M	40.4M	54.14M	69.9M
Other Income/Expense	-7.79M	-15.46M	-19.68M	-16.14M	-28.43M	-57.74M	-34.08M	-40.4M	-54.14M	-69.9M
Pretax Income+	121.09M	176.17M	192.76M	186.69M	148.49M	91.52M	443.92M	606.7M	284.29M	-172.57M
Pretax Margin %	8.28%	9.26%	9.69%	8.74%	6.68%	3.82%	11.14%	11.57%	7.5%	-5.78%
Income Tax+	39.2M	70.33M	60.2M	44.94M	34.5M	20.86M	116.53M	162.65M	73.61M	-25.59M
Effective Tax Rate %	67.63%	60.08%	68.77%	75.93%	76.77%	77.21%	73.75%	73.19%	74.11%	85.17%
Net Income+	81.89M	105.84M	132.56M	141.74M	113.99M	70.67M	327.39M	444.05M	210.68M	-146.98M
Net Margin %	5.6%	5.56%	6.67%	6.64%	5.13%	2.95%	8.22%	8.47%	5.56%	-4.93%
Net Income Growth %	146.53%	29.24%	25.25%	6.93%	-19.58%	-38.01%	363.3%	35.63%	-52.56%	-169.76%
Net Income (Continuing)	81.89M	105.84M	132.56M	141.74M	113.99M	70.67M	327.39M	444.05M	210.68M	-146.98M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)+	1.68	2.15	2.68	2.91	2.40	1.48	6.81	9.90	5.36	-3.85
EPS Growth %	143.48%	27.98%	24.65%	8.58%	-17.53%	-38.33%	360.14%	45.37%	-45.86%	-171.83%
EPS (Basic)	1.72	2.21	2.77	2.99	2.44	1.49	6.87	9.96	5.38	-3.85
Diluted Shares Outstanding	48.84M	49.27M	49.43M	48.67M	47.59M	47.69M	48.05M	44.87M	39.34M	38.19M
Basic Shares Outstanding	47.52M	47.95M	47.81M	47.37M	46.7M	47.42M	47.69M	44.59M	39.17M	38.19M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	375.63M	450.63M	474.15M	482.17M	560.5M	533.74M	1.35B	1.09B	841.68M	594.91M
Cash & Short-Term Investments	9.58M	10.62M	15.15M	13.86M	82.98M	29.21M	180.93M	64.52M	32.94M	10.65M
Cash Only	9.58M	10.62M	15.15M	13.86M	82.98M	29.21M	180.93M	64.52M	32.94M	10.65M
Short-Term Investments	0	0	0	0	0	0	0	0	0	0
Accounts Receivable	332.49M	391.57M	407.41M	416.81M	431.38M	450.08M	1.03B	953.25M	746.54M	519.98M
Days Sales Outstanding	82.95	75.13	74.78	71.22	70.86	68.63	94.25	66.36	71.91	63.61
Inventory	25.52M	34.46M	57.91M	39.54M	0	38.85M	0	0	0	0
Days Inventory Outstanding	9.37	9.81	15.73	10.02	-	8.85	-	-	-	-
Other Current Assets	20.04M	34.25M	35.09M	39.09M	34.46M	1.96M	66.83M	57.16M	40.32M	41.77M
Total Non-Current Assets+	504.8M	736.25M	779.8M	1.01B	1.37B	1.82B	1.78B	1.79B	2.08B	1.82B
Property, Plant & Equipment	50.13M	59.95M	73.43M	90.42M	194.7M	193.91M	154.88M	165.54M	225.93M	218.38M
Fixed Asset Turnover	29.18x	31.73x	27.08x	23.62x	11.41x	12.34x	25.72x	31.67x	16.77x	13.66x
Goodwill	204.78M	341.75M	340.6M	438.51M	595.55M	864.49M	892.34M	935.36M	1.11B	897.46M
Intangible Assets	174.97M	245.72M	227.1M	326.15M	398.47M	564.91M	514.46M	476.83M	474.13M	381.36M
Long-Term Investments	-22.43M	-21.42M	-27.04M	-27.33M	0	0	0	0	0	0
Other Non-Current Assets	74.92M	88.82M	138.68M	155.48M	182.42M	129.26M	221.15M	216.97M	271.1M	297.78M
Total Assets+	880.43M	1.19B	1.25B	1.49B	1.93B	2.35B	3.13B	2.89B	2.92B	2.42B
Asset Turnover	1.66x	1.60x	1.59x	1.43x	1.15x	1.02x	1.27x	1.82x	1.30x	1.24x
Asset Growth %	29.11%	34.81%	5.65%	19.04%	29.4%	21.84%	33.07%	-7.78%	1.25%	-17.39%
Total Current Liabilities+	251.02M	274.79M	265.27M	307.27M	378.11M	422.96M	969.39M	857.93M	656.12M	545.78M
Accounts Payable	84.94M	85.36M	73.21M	82.43M	102.55M	107.45M	339.01M	373.32M	177.11M	100.92M
Days Payables Outstanding	31.2	24.29	19.88	20.9	25.31	24.48	46.26	38.64	25.45	17.84
Short-Term Debt	37.5M	3.75M	0	0	0	4.69M	0	0	0	0
Deferred Revenue (Current)	5.62M	8.92M	8.38M	12.37M	11.79M	11M	157.05M	33.29M	20.01M	66.36M
Other Current Liabilities	25.68M	68.76M	62.26M	88.79M	149.71M	167.37M	250.48M	251.95M	223.39M	237.53M
Current Ratio	1.50x	1.64x	1.79x	1.57x	1.48x	1.26x	1.39x	1.27x	1.28x	1.09x
Quick Ratio	1.39x	1.51x	1.57x	1.44x	1.48x	1.17x	1.39x	1.27x	1.28x	1.09x
Cash Conversion Cycle	61.12	60.65	70.63	60.35	-	53	-	-	-	-
Total Non-Current Liabilities+	281.56M	462.71M	426.16M	546.46M	816.8M	1.11B	1B	986.78M	1.44B	1.16B
Long-Term Debt	180.99M	359.19M	319.84M	440.61M	617.16M	857.96M	842.32M	843.5M	1.3B	1.06B
Capital Lease Obligations	0	0	0	0	91.21M	77.8M	13.36M	9.36M	37.6M	35.73M
Deferred Tax Liabilities	22.43M	21.42M	27.04M	27.33M	46.62M	0	47.81M	22.71M	23.35M	0
Other Non-Current Liabilities	78.13M	103.52M	106.31M	77.66M	61.81M	107.91M	96.99M	111.21M	71.38M	71.72M
Total Liabilities	532.57M	737.5M	691.43M	853.73M	1.19B	1.53B	1.97B	1.84B	2.09B	1.71B
Total Debt+	218.49M	362.94M	319.84M	440.61M	722.31M	955.48M	867.07M	860.96M	1.35B	1.1B
Net Debt	208.91M	352.32M	304.7M	426.75M	639.33M	926.27M	686.14M	796.43M	1.32B	1.09B
Debt / Equity	0.63x	0.81x	0.57x	0.69x	0.98x	1.17x	0.75x	0.82x	1.62x	1.55x
Debt / EBITDA	1.46x	1.64x	1.31x	1.81x	3.07x	3.92x	1.49x	1.10x	2.70x	15.44x
Net Debt / EBITDA	1.39x	1.59x	1.25x	1.75x	2.72x	3.80x	1.18x	1.02x	2.64x	15.29x
Interest Coverage	16.54x	12.39x	10.80x	12.56x	6.22x	2.59x	14.03x	16.02x	6.25x	-1.47x
Total Equity+	347.86M	449.38M	562.53M	638.99M	736.74M	819.68M	1.16B	1.04B	831.26M	706.62M
Equity Growth %	35.58%	29.18%	25.18%	13.59%	15.3%	11.26%	41.77%	-10.19%	-20.35%	-14.99%
Book Value per Share	7.12	9.12	11.38	13.13	15.48	17.19	24.19	23.26	21.13	18.50
Total Shareholders' Equity	347.86M	449.38M	562.53M	638.99M	736.74M	819.68M	1.16B	1.04B	831.26M	706.62M
Common Stock	477K	481K	484K	488K	493K	496K	498K	501K	504K	507K
Retained Earnings	-96.17M	9.67M	142.23M	286.06M	400.05M	469.56M	796.95M	1.24B	1.45B	1.3B
Treasury Stock	0	-13.26M	-33.42M	-100.44M	-119.14M	-119.14M	-121.83M	-698.6M	-1.13B	-1.13B
Accumulated OCI	-183K	1K	-112K	151K	152K	40K	-295K	-939K	-423K	-11K
Minority Interest	0	0	0	0	0	0	0	0	0	0

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	57.05M	131.85M	115.26M	226.99M	224.86M	256.83M	305.36M	653.73M	372.17M	320.42M
Operating CF Margin %	3.9%	6.93%	5.8%	10.63%	10.12%	10.73%	7.66%	12.47%	9.82%	10.74%
Operating CF Growth %	106.13%	131.1%	-12.58%	96.94%	-0.94%	14.21%	18.9%	114.09%	-43.07%	-13.9%
Net Income	81.89M	105.84M	132.56M	141.74M	113.99M	70.67M	327.39M	444.05M	210.68M	-146.98M
Depreciation & Amortization	20.95M	29.62M	32.28M	41.24M	58.52M	94.19M	103.7M	137.11M	160.93M	173.78M
Stock-Based Compensation	10.28M	11.4M	10.24M	10.81M	16.24M	20.46M	25.22M	30.07M	18.02M	23.32M
Deferred Taxes	12.68M	-9.42M	5.61M	-667K	913K	-21.63M	-16.29M	-24.61M	-12.93M	-51.07M
Other Non-Cash Items	1.58M	11.12M	12.85M	2.25M	16.22M	26.01M	8.84M	67.68M	45.6M	235.46M
Working Capital Changes	-70.33M	-16.7M	-78.27M	31.61M	18.98M	67.13M	-143.49M	-558K	-50.13M	85.91M
Change in Receivables	-98.02M	-57.16M	-10.64M	-10.58M	5.71M	-8.61M	-585.27M	20.04M	224.85M	219.44M
Change in Inventory	-7.34M	-3.34M	-32.63M	14.56M	-1.93M	-5.56M	-256.12M	0	0	0
Change in Payables	29.61M	17.7M	-7.86M	17.15M	1.93M	5.56M	256.12M	0	0	0
Cash from Investing+	-116.83M	-257.36M	-33.45M	-279.34M	-291.82M	-538.17M	-107.4M	-170.71M	-412.49M	-79.94M
Capital Expenditures	-27.01M	-21.96M	-26.53M	-36.39M	-36.46M	-39.1M	-53.66M	-75.83M	-103.69M	-80.89M
CapEx % of Revenue	1.85%	1.15%	1.33%	1.7%	1.64%	1.63%	1.35%	1.45%	2.74%	2.71%
Acquisitions	-85.07M	-218.34M	-1.5M	-217.36M	-247.91M	-476.43M	-41.26M	-69.5M	-292.1M	0
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	-3M	-5.91M	-8.62M	-10.67M	-13.29M	-7.66M	-8.99M	-26.61M	-26.6M	-6.76M
Cash from Financing+	56.2M	126.29M	-77.19M	37.51M	136.6M	211.49M	-34.9M	-591.87M	10.73M	-259.45M
Debt Issued (Net)	57M	149.68M	-44.06M	120M	180M	240.54M	-21.88M	0	459.7M	-250M
Equity Issued (Net)	0	-1000K	-1000K	-1000K	-1000K	-1000K	-1000K	-1000K	-1000K	0
Dividends Paid	0	0	0	0	0	0	0	0	0	0
Share Repurchases	-11.91M	-13.26M	-20.16M	-67.01M	-18.7M	-6.93M	-2.69M	-576.77M	-424.74M	0
Other Financing	-796K	-10.13M	-12.97M	-15.48M	-24.7M	-22.13M	-10.33M	-15.1M	-24.23M	-9.45M
Net Change in Cash	-3.5M	1.05M	4.53M	-14.57M	69.64M	-69.97M	162.72M	-108.84M	-29.6M	-18.97M
Free Cash Flow+	30.04M	109.89M	88.73M	190.61M	188.4M	217.72M	251.69M	572.81M	266.78M	239.53M
FCF Margin %	2.05%	5.78%	4.46%	8.92%	8.48%	9.1%	6.32%	10.92%	7.04%	8.03%
FCF Growth %	251.63%	265.79%	-19.26%	114.81%	-1.16%	15.56%	15.6%	127.58%	-53.43%	-10.21%
FCF per Share	0.62	2.23	1.80	3.92	3.96	4.57	5.24	12.77	6.78	6.27
FCF Conversion (FCF/Net Income)	0.70x	1.25x	0.87x	1.60x	1.97x	3.63x	0.93x	1.47x	1.77x	-2.18x
Interest Paid	-5.81M	8.06M	17.94M	21.28M	23.73M	22.65M	38.09M	37.52M	48.1M	61.03M
Taxes Paid	-33.13M	73.37M	73.75M	30.59M	37.75M	46.26M	106.38M	213.81M	78.26M	28.15M

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	27.1%	26.55%	26.2%	23.59%	16.57%	9.08%	33.04%	40.26%	22.47%	-19.11%
Return on Invested Capital (ROIC)	20.08%	21.16%	19.09%	15.74%	10.87%	7.17%	19.95%	26.32%	12.73%	-3.91%
Gross Margin	32.08%	32.58%	32.41%	32.6%	33.46%	33.08%	32.87%	32.74%	32.98%	30.81%
Net Margin	5.6%	5.56%	6.67%	6.64%	5.13%	2.95%	8.22%	8.47%	5.56%	-4.93%
Debt / Equity	0.63x	0.81x	0.57x	0.69x	0.98x	1.17x	0.75x	0.82x	1.62x	1.55x
Interest Coverage	16.54x	12.39x	10.80x	12.56x	6.22x	2.59x	14.03x	16.02x	6.25x	-1.47x
FCF Conversion	0.70x	1.25x	0.87x	1.60x	1.97x	3.63x	0.93x	1.47x	1.77x	-2.18x
Revenue Growth	41.22%	30.02%	4.53%	7.42%	4.03%	7.72%	66.45%	31.6%	-27.73%	-21.26%

US Stock Screener

...

AMN Healthcare Services, Inc. (AMN) 10-Year Financial Performance & Capital Metrics

AMN •

HealthcareHealthcare FacilitiesHealthcare staffing and facility services

Revenue $2.98B -21.3%
EBITDA $71M -85.8%
Net Income -$147M -169.8%
EPS (Diluted) -3.85 -171.8%
Gross Margin 30.81% -6.6%
EBITDA Margin 2.38% -81.9%
Operating Margin -3.44% -138.5%
Net Margin -4.93% -188.6%
ROE -19.11% -185.1%
ROIC -3.91% -130.7%
Debt/Equity 1.55 -4.4%
Interest Coverage -1.47 -123.5%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Share count reduced 2.9% through buybacks
✓Trading at only 1.1x book value
✓Efficient asset utilization: 1.2x turnover

✗Weaknesses

No significant weaknesses identified

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y11.16%

5Y6.07%

3Y-9.19%

TTM-8.49%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM34.89%

EPS CAGR

10Y-

5Y-

3Y-

TTM35.36%

ROCE

10Y Avg17.51%

5Y Avg14.71%

3Y Avg13.88%

Latest-4.96%

Peer Comparison

Healthcare staffing and facility services

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
CCELCryo-Cell International, Inc.	27.15M	3.37	67.40	2.05%	1.26%		13.29%
HCSGHealthcare Services Group, Inc.	1.67B	21.77	26.88	7.08%	2.2%	8.01%	8.32%	0.03
SOLVSolventum Corporation	12.87B	74.20	8.36	0.86%	18.69%	30.82%		1.00
AMSAmerican Shared Hospital Services	13.74M	2.11	6.39	32.9%	-7.65%	-7.87%		0.77
SYRASyra Health Corp. Class A Common Stock	60K	0.10	-0.19	44.73%	-16.89%	-57.31%		0.16
AMNAMN Healthcare Services, Inc.	987.48M	19.48	-5.06	-21.26%	-3.5%	-14.9%	24.26%	1.55
CCRNCross Country Healthcare, Inc.	280.81M	8.70	-19.77	-33.46%	-1.39%	-3.84%	39.67%	0.01

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	1.46B	1.9B	1.99B	2.14B	2.22B	2.39B	3.98B	5.24B	3.79B	2.98B
Revenue Growth %	41.22%	30.02%	4.53%	7.42%	4.03%	7.72%	66.45%	31.6%	-27.73%	-21.26%
Cost of Goods Sold+	993.7M	1.28B	1.34B	1.44B	1.48B	1.6B	2.67B	3.53B	2.54B	2.06B
COGS % of Revenue	67.92%	67.42%	67.59%	67.4%	66.54%	66.92%	67.13%	67.26%	67.02%	69.19%
Gross Profit+	469.36M	619.72M	644.42M	696.38M	743.47M	791.78M	1.31B	1.72B	1.25B	919.38M
Gross Margin %	32.08%	32.58%	32.41%	32.6%	33.46%	33.08%	32.87%	32.74%	32.98%	30.81%
Gross Profit Growth %	48.48%	32.04%	3.98%	8.06%	6.76%	6.5%	65.4%	31.08%	-27.21%	-26.43%
Operating Expenses+	340.48M	428.09M	431.98M	493.56M	566.55M	642.51M	831.6M	1.07B	911.15M	1.02B
OpEx % of Revenue	23.27%	22.5%	21.72%	23.11%	25.5%	26.84%	20.87%	20.4%	24.05%	34.25%
Selling, General & Admin	319.53M	398.47M	399.7M	452.32M	508.03M	549.75M	730.45M	936.58M	756.24M	632.49M
SG&A % of Revenue	21.84%	20.95%	20.1%	21.18%	22.86%	22.97%	18.33%	17.86%	19.96%	21.2%
Research & Development	0	0	0	0	0	0	0	0	0	0
R&D % of Revenue	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	20.95M	29.62M	32.28M	41.24M	58.52M	92.77M	101.15M	133.01M	154.91M	389.56M
Operating Income+	128.88M	191.63M	212.44M	202.83M	176.91M	149.26M	478M	647.1M	338.43M	-102.67M
Operating Margin %	8.81%	10.07%	10.68%	9.5%	7.96%	6.24%	12%	12.34%	8.93%	-3.44%
Operating Income Growth %	89.8%	48.69%	10.86%	-4.52%	-12.78%	-15.63%	220.23%	35.38%	-47.7%	-130.34%
EBITDA+	149.83M	221.25M	244.72M	244.06M	235.44M	243.45M	581.7M	784.21M	499.36M	71.11M
EBITDA Margin %	10.24%	11.63%	12.31%	11.43%	10.6%	10.17%	14.6%	14.96%	13.18%	2.38%
EBITDA Growth %	78.59%	47.67%	10.61%	-0.27%	-3.54%	3.41%	138.94%	34.82%	-36.32%	-85.76%
D&A (Non-Cash Add-back)	20.95M	29.62M	32.28M	41.24M	58.52M	94.19M	103.7M	137.11M	160.93M	173.78M
EBIT	128.88M	191.63M	212.44M	202.83M	176.91M	149.26M	478M	647.1M	338.43M	-102.67M
Net Interest Income+	-7.79M	-15.46M	-19.68M	-16.14M	-28.43M	-57.74M	-34.08M	-40.4M	-54.14M	-69.9M
Interest Income	0	0	0	0	0	0	0	0	0	0
Interest Expense	7.79M	15.46M	19.68M	16.14M	28.43M	57.74M	34.08M	40.4M	54.14M	69.9M
Other Income/Expense	-7.79M	-15.46M	-19.68M	-16.14M	-28.43M	-57.74M	-34.08M	-40.4M	-54.14M	-69.9M
Pretax Income+	121.09M	176.17M	192.76M	186.69M	148.49M	91.52M	443.92M	606.7M	284.29M	-172.57M
Pretax Margin %	8.28%	9.26%	9.69%	8.74%	6.68%	3.82%	11.14%	11.57%	7.5%	-5.78%
Income Tax+	39.2M	70.33M	60.2M	44.94M	34.5M	20.86M	116.53M	162.65M	73.61M	-25.59M
Effective Tax Rate %	67.63%	60.08%	68.77%	75.93%	76.77%	77.21%	73.75%	73.19%	74.11%	85.17%
Net Income+	81.89M	105.84M	132.56M	141.74M	113.99M	70.67M	327.39M	444.05M	210.68M	-146.98M
Net Margin %	5.6%	5.56%	6.67%	6.64%	5.13%	2.95%	8.22%	8.47%	5.56%	-4.93%
Net Income Growth %	146.53%	29.24%	25.25%	6.93%	-19.58%	-38.01%	363.3%	35.63%	-52.56%	-169.76%
Net Income (Continuing)	81.89M	105.84M	132.56M	141.74M	113.99M	70.67M	327.39M	444.05M	210.68M	-146.98M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)+	1.68	2.15	2.68	2.91	2.40	1.48	6.81	9.90	5.36	-3.85
EPS Growth %	143.48%	27.98%	24.65%	8.58%	-17.53%	-38.33%	360.14%	45.37%	-45.86%	-171.83%
EPS (Basic)	1.72	2.21	2.77	2.99	2.44	1.49	6.87	9.96	5.38	-3.85
Diluted Shares Outstanding	48.84M	49.27M	49.43M	48.67M	47.59M	47.69M	48.05M	44.87M	39.34M	38.19M
Basic Shares Outstanding	47.52M	47.95M	47.81M	47.37M	46.7M	47.42M	47.69M	44.59M	39.17M	38.19M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	375.63M	450.63M	474.15M	482.17M	560.5M	533.74M	1.35B	1.09B	841.68M	594.91M
Cash & Short-Term Investments	9.58M	10.62M	15.15M	13.86M	82.98M	29.21M	180.93M	64.52M	32.94M	10.65M
Cash Only	9.58M	10.62M	15.15M	13.86M	82.98M	29.21M	180.93M	64.52M	32.94M	10.65M
Short-Term Investments	0	0	0	0	0	0	0	0	0	0
Accounts Receivable	332.49M	391.57M	407.41M	416.81M	431.38M	450.08M	1.03B	953.25M	746.54M	519.98M
Days Sales Outstanding	82.95	75.13	74.78	71.22	70.86	68.63	94.25	66.36	71.91	63.61
Inventory	25.52M	34.46M	57.91M	39.54M	0	38.85M	0	0	0	0
Days Inventory Outstanding	9.37	9.81	15.73	10.02	-	8.85	-	-	-	-
Other Current Assets	20.04M	34.25M	35.09M	39.09M	34.46M	1.96M	66.83M	57.16M	40.32M	41.77M
Total Non-Current Assets+	504.8M	736.25M	779.8M	1.01B	1.37B	1.82B	1.78B	1.79B	2.08B	1.82B
Property, Plant & Equipment	50.13M	59.95M	73.43M	90.42M	194.7M	193.91M	154.88M	165.54M	225.93M	218.38M
Fixed Asset Turnover	29.18x	31.73x	27.08x	23.62x	11.41x	12.34x	25.72x	31.67x	16.77x	13.66x
Goodwill	204.78M	341.75M	340.6M	438.51M	595.55M	864.49M	892.34M	935.36M	1.11B	897.46M
Intangible Assets	174.97M	245.72M	227.1M	326.15M	398.47M	564.91M	514.46M	476.83M	474.13M	381.36M
Long-Term Investments	-22.43M	-21.42M	-27.04M	-27.33M	0	0	0	0	0	0
Other Non-Current Assets	74.92M	88.82M	138.68M	155.48M	182.42M	129.26M	221.15M	216.97M	271.1M	297.78M
Total Assets+	880.43M	1.19B	1.25B	1.49B	1.93B	2.35B	3.13B	2.89B	2.92B	2.42B
Asset Turnover	1.66x	1.60x	1.59x	1.43x	1.15x	1.02x	1.27x	1.82x	1.30x	1.24x
Asset Growth %	29.11%	34.81%	5.65%	19.04%	29.4%	21.84%	33.07%	-7.78%	1.25%	-17.39%
Total Current Liabilities+	251.02M	274.79M	265.27M	307.27M	378.11M	422.96M	969.39M	857.93M	656.12M	545.78M
Accounts Payable	84.94M	85.36M	73.21M	82.43M	102.55M	107.45M	339.01M	373.32M	177.11M	100.92M
Days Payables Outstanding	31.2	24.29	19.88	20.9	25.31	24.48	46.26	38.64	25.45	17.84
Short-Term Debt	37.5M	3.75M	0	0	0	4.69M	0	0	0	0
Deferred Revenue (Current)	5.62M	8.92M	8.38M	12.37M	11.79M	11M	157.05M	33.29M	20.01M	66.36M
Other Current Liabilities	25.68M	68.76M	62.26M	88.79M	149.71M	167.37M	250.48M	251.95M	223.39M	237.53M
Current Ratio	1.50x	1.64x	1.79x	1.57x	1.48x	1.26x	1.39x	1.27x	1.28x	1.09x
Quick Ratio	1.39x	1.51x	1.57x	1.44x	1.48x	1.17x	1.39x	1.27x	1.28x	1.09x
Cash Conversion Cycle	61.12	60.65	70.63	60.35	-	53	-	-	-	-
Total Non-Current Liabilities+	281.56M	462.71M	426.16M	546.46M	816.8M	1.11B	1B	986.78M	1.44B	1.16B
Long-Term Debt	180.99M	359.19M	319.84M	440.61M	617.16M	857.96M	842.32M	843.5M	1.3B	1.06B
Capital Lease Obligations	0	0	0	0	91.21M	77.8M	13.36M	9.36M	37.6M	35.73M
Deferred Tax Liabilities	22.43M	21.42M	27.04M	27.33M	46.62M	0	47.81M	22.71M	23.35M	0
Other Non-Current Liabilities	78.13M	103.52M	106.31M	77.66M	61.81M	107.91M	96.99M	111.21M	71.38M	71.72M
Total Liabilities	532.57M	737.5M	691.43M	853.73M	1.19B	1.53B	1.97B	1.84B	2.09B	1.71B
Total Debt+	218.49M	362.94M	319.84M	440.61M	722.31M	955.48M	867.07M	860.96M	1.35B	1.1B
Net Debt	208.91M	352.32M	304.7M	426.75M	639.33M	926.27M	686.14M	796.43M	1.32B	1.09B
Debt / Equity	0.63x	0.81x	0.57x	0.69x	0.98x	1.17x	0.75x	0.82x	1.62x	1.55x
Debt / EBITDA	1.46x	1.64x	1.31x	1.81x	3.07x	3.92x	1.49x	1.10x	2.70x	15.44x
Net Debt / EBITDA	1.39x	1.59x	1.25x	1.75x	2.72x	3.80x	1.18x	1.02x	2.64x	15.29x
Interest Coverage	16.54x	12.39x	10.80x	12.56x	6.22x	2.59x	14.03x	16.02x	6.25x	-1.47x
Total Equity+	347.86M	449.38M	562.53M	638.99M	736.74M	819.68M	1.16B	1.04B	831.26M	706.62M
Equity Growth %	35.58%	29.18%	25.18%	13.59%	15.3%	11.26%	41.77%	-10.19%	-20.35%	-14.99%
Book Value per Share	7.12	9.12	11.38	13.13	15.48	17.19	24.19	23.26	21.13	18.50
Total Shareholders' Equity	347.86M	449.38M	562.53M	638.99M	736.74M	819.68M	1.16B	1.04B	831.26M	706.62M
Common Stock	477K	481K	484K	488K	493K	496K	498K	501K	504K	507K
Retained Earnings	-96.17M	9.67M	142.23M	286.06M	400.05M	469.56M	796.95M	1.24B	1.45B	1.3B
Treasury Stock	0	-13.26M	-33.42M	-100.44M	-119.14M	-119.14M	-121.83M	-698.6M	-1.13B	-1.13B
Accumulated OCI	-183K	1K	-112K	151K	152K	40K	-295K	-939K	-423K	-11K
Minority Interest	0	0	0	0	0	0	0	0	0	0

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	57.05M	131.85M	115.26M	226.99M	224.86M	256.83M	305.36M	653.73M	372.17M	320.42M
Operating CF Margin %	3.9%	6.93%	5.8%	10.63%	10.12%	10.73%	7.66%	12.47%	9.82%	10.74%
Operating CF Growth %	106.13%	131.1%	-12.58%	96.94%	-0.94%	14.21%	18.9%	114.09%	-43.07%	-13.9%
Net Income	81.89M	105.84M	132.56M	141.74M	113.99M	70.67M	327.39M	444.05M	210.68M	-146.98M
Depreciation & Amortization	20.95M	29.62M	32.28M	41.24M	58.52M	94.19M	103.7M	137.11M	160.93M	173.78M
Stock-Based Compensation	10.28M	11.4M	10.24M	10.81M	16.24M	20.46M	25.22M	30.07M	18.02M	23.32M
Deferred Taxes	12.68M	-9.42M	5.61M	-667K	913K	-21.63M	-16.29M	-24.61M	-12.93M	-51.07M
Other Non-Cash Items	1.58M	11.12M	12.85M	2.25M	16.22M	26.01M	8.84M	67.68M	45.6M	235.46M
Working Capital Changes	-70.33M	-16.7M	-78.27M	31.61M	18.98M	67.13M	-143.49M	-558K	-50.13M	85.91M
Change in Receivables	-98.02M	-57.16M	-10.64M	-10.58M	5.71M	-8.61M	-585.27M	20.04M	224.85M	219.44M
Change in Inventory	-7.34M	-3.34M	-32.63M	14.56M	-1.93M	-5.56M	-256.12M	0	0	0
Change in Payables	29.61M	17.7M	-7.86M	17.15M	1.93M	5.56M	256.12M	0	0	0
Cash from Investing+	-116.83M	-257.36M	-33.45M	-279.34M	-291.82M	-538.17M	-107.4M	-170.71M	-412.49M	-79.94M
Capital Expenditures	-27.01M	-21.96M	-26.53M	-36.39M	-36.46M	-39.1M	-53.66M	-75.83M	-103.69M	-80.89M
CapEx % of Revenue	1.85%	1.15%	1.33%	1.7%	1.64%	1.63%	1.35%	1.45%	2.74%	2.71%
Acquisitions	-85.07M	-218.34M	-1.5M	-217.36M	-247.91M	-476.43M	-41.26M	-69.5M	-292.1M	0
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	-3M	-5.91M	-8.62M	-10.67M	-13.29M	-7.66M	-8.99M	-26.61M	-26.6M	-6.76M
Cash from Financing+	56.2M	126.29M	-77.19M	37.51M	136.6M	211.49M	-34.9M	-591.87M	10.73M	-259.45M
Debt Issued (Net)	57M	149.68M	-44.06M	120M	180M	240.54M	-21.88M	0	459.7M	-250M
Equity Issued (Net)	0	-1000K	-1000K	-1000K	-1000K	-1000K	-1000K	-1000K	-1000K	0
Dividends Paid	0	0	0	0	0	0	0	0	0	0
Share Repurchases	-11.91M	-13.26M	-20.16M	-67.01M	-18.7M	-6.93M	-2.69M	-576.77M	-424.74M	0
Other Financing	-796K	-10.13M	-12.97M	-15.48M	-24.7M	-22.13M	-10.33M	-15.1M	-24.23M	-9.45M
Net Change in Cash	-3.5M	1.05M	4.53M	-14.57M	69.64M	-69.97M	162.72M	-108.84M	-29.6M	-18.97M
Free Cash Flow+	30.04M	109.89M	88.73M	190.61M	188.4M	217.72M	251.69M	572.81M	266.78M	239.53M
FCF Margin %	2.05%	5.78%	4.46%	8.92%	8.48%	9.1%	6.32%	10.92%	7.04%	8.03%
FCF Growth %	251.63%	265.79%	-19.26%	114.81%	-1.16%	15.56%	15.6%	127.58%	-53.43%	-10.21%
FCF per Share	0.62	2.23	1.80	3.92	3.96	4.57	5.24	12.77	6.78	6.27
FCF Conversion (FCF/Net Income)	0.70x	1.25x	0.87x	1.60x	1.97x	3.63x	0.93x	1.47x	1.77x	-2.18x
Interest Paid	-5.81M	8.06M	17.94M	21.28M	23.73M	22.65M	38.09M	37.52M	48.1M	61.03M
Taxes Paid	-33.13M	73.37M	73.75M	30.59M	37.75M	46.26M	106.38M	213.81M	78.26M	28.15M

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	27.1%	26.55%	26.2%	23.59%	16.57%	9.08%	33.04%	40.26%	22.47%	-19.11%
Return on Invested Capital (ROIC)	20.08%	21.16%	19.09%	15.74%	10.87%	7.17%	19.95%	26.32%	12.73%	-3.91%
Gross Margin	32.08%	32.58%	32.41%	32.6%	33.46%	33.08%	32.87%	32.74%	32.98%	30.81%
Net Margin	5.6%	5.56%	6.67%	6.64%	5.13%	2.95%	8.22%	8.47%	5.56%	-4.93%
Debt / Equity	0.63x	0.81x	0.57x	0.69x	0.98x	1.17x	0.75x	0.82x	1.62x	1.55x
Interest Coverage	16.54x	12.39x	10.80x	12.56x	6.22x	2.59x	14.03x	16.02x	6.25x	-1.47x
FCF Conversion	0.70x	1.25x	0.87x	1.60x	1.97x	3.63x	0.93x	1.47x	1.77x	-2.18x
Revenue Growth	41.22%	30.02%	4.53%	7.42%	4.03%	7.72%	66.45%	31.6%	-27.73%	-21.26%

AMN Healthcare Services, Inc. (AMN) 10-Year Financial Performance & Capital Metrics

Key Insights

✓Strengths

✗Weaknesses

Price & Volume

Growth Metrics

Revenue CAGR

Profit (Net Income) CAGR

EPS CAGR

ROCE

Peer Comparison

Compare AMN vs Peers

vs SOLV

vs HCSG

Compare Top 5

Profit & Loss

Balance Sheet

Cash Flow

Key Ratios

Deep Dive Analysis

Valuation Overview

Total Return Calculator

Dividend History

Earnings History

Price History

Revenue History

Financial Ratios

AMN Healthcare Services, Inc. (AMN) 10-Year Financial Performance & Capital Metrics

Key Insights

✓Strengths

✗Weaknesses

Price & Volume

Growth Metrics

Revenue CAGR

Profit (Net Income) CAGR

EPS CAGR

ROCE

Peer Comparison

Compare AMN vs Peers

vs SOLV

vs HCSG

Compare Top 5

Profit & Loss

Balance Sheet

Cash Flow

Key Ratios

Deep Dive Analysis

Valuation Overview

Total Return Calculator

Dividend History

Earnings History

Price History

Revenue History

Financial Ratios